Obesity Clinical Trial
Official title:
Effect of Isocaloric Ultra Processed Versus Unprocessed Diets on Insulin Sensitivity
Verified date | April 2019 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Background:
Increases in obesity, diabetes, and some metabolic disorders may be linked to how much
processed foods people eat. Researchers want to learn more about how processed foods affect
metabolic health.
Objective:
To learn about how a processed versus unprocessed diet affects the body.
Eligibility:
Men ages 18-50 with stable weight and risk factors for diabetes
Design:
Participants will be screened over 3 visits. Screening includes:
- Medical history and physical exam
- Heart and blood tests
- Psychiatric questions
- Questions about eating, sleeping, and economic status
- Riding a stationary bike
- Trying a sample meal
Between screenings, participants will eat prepared meals. They will wear an accelerometer to
measure physical activity. They will write down what foods they eat and monitor their weight.
Participants will have two 4-week stays in the clinic. They will:
- Eat a special diet
- Have activity and weight monitored
- Drink water and collect urine samples to measure how many calories they are burning
- Have resting energy expenditure measured with a clear hood over the head
- Have a scan to measure body fat and bone density using low-dose x-rays
- Have a scan on a table that slides into a metal cylinder in a strong magnetic field.
They will get earplugs for the loud noises.
- Have an ultrasound test to measure blood vessels
- Have insulin and glucose infused into an arm vein. Blood will be taken over 10 hours
through a plastic tube in the wrist. This will happen 4 times.
- Spend multiple 24-hour periods in a room that measures oxygen used and carbon dioxide
produced.
- Give blood, urine and stool samples
- Answer questionnaires and do computer tasks
Status | Completed |
Enrollment | 5 |
Est. completion date | April 5, 2019 |
Est. primary completion date | April 5, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 50 Years |
Eligibility |
- INCLUSION CRITERIA: 1. Adult men, age 18-50 years 2. Weight stable (< plus or minus 5 % over past 6 months) 3. Body mass index (BMI) greater than or equal to 25 kg/m^2 4. Plasma triglycerides > 150 mg/dl (Caucasian) or >140 mg/dl (African American) 5. Homeostatic model of insulin resistance (HOMA-IR) > 2 6. Able to complete daily bouts of stationary cycling at a moderate rate and intensity with a HR equal to or greater than 0.3x(220-age-HRrest)+HRrest but not exceeding 0.6x(220-age- HRrest)+HRrest and no signs of arrhythmia 7. Written informed consent 8. Willing to eat all the food provided in the study 9. Willing to cease their habitual caffeine intake during the study, beginning one week prior to each inpatient admission EXCLUSION CRITERIA: 1. Evidence of metabolic or cardiovascular disease, or disease that may influence metabolism (e.g. cancer, diabetes, thyroid disease) 2. Body weight >400 lbs. (weight limit of magnetic resonance spectroscopy gantry) 3. Taking any prescription medication or other drug that may influence metabolism (e.g. diet/weight-loss medication, asthma medication, blood pressure medication, psychiatric medications, corticosteroids, or other medications at the discretion of the PI and/or study team) 4. Hematocrit < 40% 5. Participating in a regular exercise program (> 2h/week of vigorous activity) 6. Caffeine consumption > 300 mg/day 7. Regular use of alcohol (> 2 drinks per day), tobacco (smoking or chewing) amphetamines, cocaine, heroin, or marijuana over past 6 months 8. Past or present history of eating disorder (including binge eating) or psychiatric disease, including claustrophobia since part of the protocol will involve being confined to a small room for whole-body indirect calorimetry and being in an MRI scanner for liver fat measures 9. Implants, devices, or foreign objects implanted in the body that interfere with the Magnetic Resonance procedures. 10. Volunteers with strict dietary concerns (e.g. vegetarian or kosher diet, food allergies) 11. Volunteers unwilling or unable to give informed consent 12. Non-English speakers due to unavailability of required questionnaires in other languages. |
Country | Name | City | State |
---|---|---|---|
United States | National Institutes of Health Clinical Center | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
United States,
Monteiro CA, Moubarac JC, Cannon G, Ng SW, Popkin B. Ultra-processed products are becoming dominant in the global food system. Obes Rev. 2013 Nov;14 Suppl 2:21-8. doi: 10.1111/obr.12107. Review. — View Citation
Tavares LF, Fonseca SC, Garcia Rosa ML, Yokoo EM. Relationship between ultra-processed foods and metabolic syndrome in adolescents from a Brazilian Family Doctor Program. Public Health Nutr. 2012 Jan;15(1):82-7. doi: 10.1017/S1368980011001571. Epub 2011 Jul 14. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | To determine changes in hepatic insulin sensitivity following a 3-week ultra-processed diet as compared to following 3 weeks of an unprocessed diet matched for calories, macronutrient composition, sugar, fiber, and sodium. | ongoing | ||
Secondary | To determine changes in hepatic triglyceride content following a 3-week ultra-processed diet as compared to 3 weeks of an unprocessed diet matched for calories, macronutrient composition, sugar, fiber, and sodium | ongoing |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |